The Richard Dawkins Foundation for Reason and Science (Official)

Patients on this new therapy survived 63% longer than those on standard chemotherapy, but the real and exciting breakthrough is that patients had no apparent side-effects (which are usually quite severe). Read up on recent breakthroughs in cancer research: http://bit.ly/2ceJWaw
by José Lourenço via Facebook at September 11, 2016 at 11:38PM
http://ift.tt/2ccqX3G